SHENZHEN, China, April 25, 2024 /PRNewswire/ -- Olight, an innovator and leader in the flashlight industry, raised $69,467.59 from a special edition of its popular EDC flashlight, the i3T 2 in a Starry Blue color, during the autism awareness charity sale held to commemorate its 17th anniversary. The total proceeds from the sale will be donated without reservation to the autism research institutions around the world, supporting the investment in autism research. Additionally, 450 pieces of

New DJI Agricultural Drones Launch Globally with Upgraded SmartFarm App SHENZHEN, China, April 25, 2024 /PRNewswire/ -- DJI, the world leader in civilian drones and creative camera technology, today announced the international launch of the Agras T50 and Agras T25 drones. Building on the popular Agras drone line, the T50 offers unmatched efficiency for larger-scale growing operations, while the lightweight T25 is designed to be more portable for smaller fields. Both drones are compatible

BEIJING, April 25, 2024 /PRNewswire/ -- At Auto China 2024, CATL (SZ.300750) unveiled Shenxing PLUS—the world's first LFP battery that achieves a range above 1,000 kilometers with 4C superfast charging. Within eight months after the launch of the Shenxing superfast charging battery in August 2023, CATL has once again pushed the boundaries of LFP battery technology, ushering in the era of superfast charging for the whole industry. Dr. Wu Kai, chief scientist of CATL   Shenxi

Fahari Link, Tatu City's new internet company, bridges the digital divide for thousands of underserved residents TATU CITY, Kenya, April 25, 2024 /PRNewswire/ -- Rendeavour, Africa's largest new city builder and the owner and developer of Tatu City, the 5,000-acre new city on Nairobi's doorstep, has created a new company to deliver high-speed internet connectivity to thousands of digitally underserved residents in nearby towns and informal settlements.   (Left to r

SEOUL, South Korea, April 25, 2024 /PRNewswire/ -- Onconic Therapeutics, a leading biotechnology company in Korea, today announced that the Ministry of Food and Drug Safety (MFDS) of Korea has approved JAQBO (zastaprazan citrate) for the treatment of erosive gastroesophageal reflux disease (GERD) in adults. JAQBO is a next-generation potassium competitive blocker (P-CAB) expected to become the new standard treatment in the market for gastric acid related diseases. JAQBO directly bi

PARIS, April 25, 2024 /PRNewswire/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion", 01157.HK) proudly showcased its latest advancements at INTERMAT, held at the Nord Villepinte Exhibition Center in Paris from April 24-27, 2024. Themed "Greener Development, Brighter Future", the display featured approximately 30 cutting-edge products across seven major categories, underscoring Zoomlion's commitment to sustainable and intelligent product solutions.

"Aiming to offer a Dengue antiviral treatment course in $100 price range" Hyundai Bioscience decides to conduct dengue clinical trials in Brazil, which has the largest number of Dengue patients and offers a fast-track approval SEOUL, South Korea, April 25, 2024 /PRNewswire/ -- Hyundai Bioscience announced on April 25th that, after multiple consultations with global clinical research organizations (CRO), it has decided to conduct clinical trials for its 'niclosamide-based Deng

LONDON, April 25, 2024 /PRNewswire/ -- The World's 50 Best Restaurants today announces its Champions of Change 2024, the heroes of hospitality at the forefront of positive action and long-term progress within the industry and their communities.  The World’s 50 Best Restaurants announces João Diamante, founder of Diamantes Na Cozinha in Rio de Janeiro and duo Caroline Caporossi and Jessica Rosval behind Roots in Modena, as Champions of Change winners for 2024 Part of

ROTTERDAM, Netherlands, April 25, 2024 /PRNewswire/ -- Huawei is presenting its innovative Intelligent Distribution Solution (IDS) at the 26th World Energy Congress in Rotterdam. Developed in collaboration with ecosystem partners, the IDS aims to tackle the electric power industry's most pressing challenges, including high line loss, unreliable service, and the burden of managing new energy loads. Huawei presents its full-scenario solutions for the electric power sector at the 26th World E

SHIJIAZHUANG, China, April 25, 2024 /PRNewswire/ -- On April 21, the 3rd Traditional Chinese Medicine Anti-Aging Conference, hosted by the World Federation of Chinese Medicine Societies, was held in Shijiazhuang. Yiling Pharmaceutical's Bazi Bushen capsule, as a representative drug of anti-aging innovative TCM widely recognized in the industry, became one of the focuses of the meeting. At the conference, many experts and scholars shared the theoretical basis and clinical research results of Bazi

Two new drama brands focusing on literary work adaptations and short series respectively Using generative AI to optimize content production and empower creators BEIJING, April 25, 2024 /PRNewswire/ -- iQIYI, an innovative market-leading online entertainment service in China, announced an exciting lineup of over 300 new titles across genres at the iQIYI 2024 World Conference held on April 23-24. The company also introduced two new drama series brands and forged multiple strategic partnerships

HONG KONG, April 25, 2024 /PRNewswire/ -- At Huawei Cloud Summit 2024 in Hong Kong, Hu Yuhai, Vice President of Huawei Hybrid Cloud, announced the release of Huawei Cloud Stack 8.3 in Hong Kong. Huawei Cloud Stack 8.3 provides more than 110 on-premises cloud services and six highlights, aiming to help government organizations and companies in Hong Kong dive into cloud and spur innovation. Huawei Cloud also launched a "Leap2Cloud" initiative to help more customers and partners in Hong

HONG KONG, April 25, 2024 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) today announced its operating results for the first quarter of 2024. In the first quarter, the Company pressed ahead with oil and gas exploration and development, advanced the enhancement of quality and efficiency, and consolidated its advantage of cost competitiveness. Net production of oil and gas and net profit attributable to equity s

The only solution for intractable cancer caused by mutations in the p53 gene Planning clinical trials targeting cancer patients with no available treatment due to p53 gene mutations SEOUL, South Korea, April 25, 2024 /PRNewswire/ -- Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost

On the 25th, announced 1Q revenue of 7.8 trillion won and operating profit of 265 billion won Stable profit structure of the energy business value chain and increased sales to the eco-friendly industry customers contributed to profit growth Secured a stable cash flow foundation to support future investment and improve shareholder returns SEOUL and INCHEON, South Korea, April 25, 2024 /PRNewswire/ -- Despite the ongoing global economic slowdown due to high interest rate and increased